Boundless Bio, Inc. 10% holder Kevin Tang buys $244,231 in BOLD shares
103,612 shares at about $2.36 each, bought on the open market between Nov 18 and Nov 20.
A Form 4 filed on Nov 20 shows Kevin Tang, a holder of more than 10% of Boundless Bio, Inc., buying 103,612 shares worth $244,231 between Nov 18 and Nov 20, at about $2.36 each.
It is an open-market purchase (transaction code P) of common stock, the kind of trade insiders make with their own money. The trade was reported within two business days, as Section 16 requires.
After the trade, the filing lists 3,152,991 shares held. It is the seventh insider purchase at Boundless Bio, Inc. reported in the last 90 days.
Details from the SEC filing:
| Company | Boundless Bio, Inc. (BOLD) |
|---|---|
| Insider | Kevin Tang |
| Role | 10% owner |
| Transaction | Open-market purchase (code P) |
| Shares | 103,612 |
| Average price | $2.36 |
| Value | $244,231 |
| Trade dates | Nov 18 to Nov 20, 2026 |
| Filed with the SEC | Nov 20, 2026, 8:59 PM ET |
| Shares held after | 3,152,991 |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
See the full details of this insider trade
Read the daily insider trading roundup · See where several insiders traded together
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.